<DOC>
	<DOC>NCT01948999</DOC>
	<brief_summary>The purpose of the study is to determine whether addition of electroconvulsive therapy to antipsychotic treatment improves the mental health of patients with treatment-resistant schizophrenia.</brief_summary>
	<brief_title>Electroconvulsive Therapy for Treatment Refractory Schizophrenia - A Randomized, Double-blinded, Sham-controlled Study</brief_title>
	<detailed_description>The purpose of the study is not achieved.</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>An ICD10 schizophrenia diagnosis F20.020.3 or F20.9 PANSS total score &gt;= 70 CGIS &gt;= 4 (Clinical Global Impression) PANSS score &gt;= 4 on minimum 2 og the following items: Delusions, Conceptual disorganization,Hallucinatory behavior, Excitement, Grandiosity, Suspiciousness, Hostility, Disorientation. Previous/current treated with clozapine or refused clozapine treatment Lack of response to at least three different antipsychotics New antipsychotic medication prescribed more than 8 weeks before inclusion Fixed dosage of antipsychotics 1 month before inclusion No chance of additional neurotropic 4 weeks before inclusion Signed informed consent and power of attorney Significant substance abuse Somatic disease that increases the risk of complications of ECT/anesthesia Epilepsy For women: Pregnancy or breastfeeding Homelessness Use of benzodiazepines (apart from tbl. oxazepam 10 mg., max 30 mg. daily) Use of antiepileptic Previous no effect on psychotic symptoms after ECT treatment (minimum 15 ECT treatments) Concrete suicidal plans</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>electroconvulsive therapy</keyword>
	<keyword>treatment-refractory schizophrenia</keyword>
</DOC>